Carolyn Y. Johnson Washington Post The highly anticipated results of a clinical trial for the pill, daraxonrasib, have been released, giving doctors hope for treating the stubbornly lethal disease.
United States (National)
Carolyn Y. Johnson
Geo Focus
Coverage Attributes:
Beta
Informative:
50
%
Data Driven:
24
%
Opinion:
7
%
Reviews:
4
%
Events:
4
%
Themes Covered:
Not enough data
Pitching Insights
Carolyn Y. Johnson primarily covers scientific and health-related topics, with a focus on groundbreaking research and medical breakthroughs in the United States. She heavily relies on data and expert commentary to support her articles, making her more likely to respond positively to pitches that can provide credible sources or data-driven insights.
As she often reports on specific scientific studies or healthcare advancements, experts who have direct knowledge of these developments or related fields would be well-suited for outreach. This could include researchers involved in recent medical breakthroughs or professionals with expertise in relevant areas of study.
Considering Carolyn’s national geographic focus, outreach should emphasize how the pitch relates specifically to the U.S. healthcare system, medical breakthroughs within the country, or any regulation impacting U.S.-based research and development efforts.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Journalists With Similar Coverage:
Based on similarity of content.
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
Publications
Most recent topics
Not enough data
